About Cambridge MedChem Consulting

Cambridge MedChem Consulting was founded in 2006 by Chris Swain to offer a range of consultancy services in drug discovery and medicinal chemistry, in particular to support academic and small or medium sized Pharma companies.

Recent activities include, providing medicinal chemistry and computational chemistry support for several projects supported by Wellcome Trust. Ongoing collaborations with a number of academic groups, small startup companies providing lead finding oversight and lead optimisation input. Portfolio review for medium and large Pharma companies, Provided licensing oversight and review of possible licensing candidates. “Honest Data Broker” for European Lead Factory.

Involved with a number of open drug discovery projects including Open Source Antibiotics, Open Source Malaria and COVID project moonshot.

Author of over 150 publications and patents and creator of Drug Discovery Resources website.

Speaker and tutor for RSC summer school and Pharma companies, Chair of RSC CICAG interest group, member of RSC BMCS group and part of the organising committee for the upcoming RSC-SCI Cambridge Medicinal Chemistry Conference, AI in Chemistry meeting, Macrocycles, and Open Chemical Sciences meetings and Computational tools for Drug Discovery workshops.

Services include...

• High-Throughput Screening analysis
• Screening or Focused molecular Library Design
• Hit to Lead project supervision
• Lead optimisation and candidate selection
• Computational support, in particular virtual screening and QSAR analysis.
• Licensing oversight
• Training courses on the drug discovery process and medicinal chemistry.

Dr Chris Swain BA MA (Cantab) PhD CChem FRSC
Cambridge MedChem Consulting,
swain@mac.com
https://www.cambridgemedchemconsulting.com